Skip to main content

Table 5 Individual characteristics and FT scores of the four profiles (N = 421)

From: Potential profile analysis of financial toxicity and its related factors among lung cancer patients

Variables

Latent profile (N [%])

H

P

C1

C2

C3

C4

Age, Y

    

4.016

0.260

≤ 45

4 (26.7)

0 (0.0)

6 (40.0)

5 (33.3)

  

46 ~ 60

27 (16.3)

12 (7.2)

56 (33.7)

71 (42.8)

  

61 ~ 75

43 (20.1)

18 (8.4)

81 (37.9)

72 (33.6)

  

> 75

8 (30.8)

3 (11.5)

7 (26.9)

8 (30.8)

  

Sex

    

1.279

0.734

Male

60 (20.6)

22 (7.5)

100 (34.2)

110 (37.7)

  

Female

22 (17.0)

11 (8.5)

50 (38.8)

46 (35.7)

  

Residence

    

30.719

 < 0.001

Urban

35 (19.9)

3 (8.0)

43 (36.3)

21 (37.8)

  

Rural

47 (14.8)

30 (9.4)

107 (33.5)

135 (42.3)

  

Medical expense insurance

    

54.114

 < 0.001

New Rural Cooperative Medical Insurance

29 (11.07)

27 (10.31)

84 (32.06)

122 (46.56)

  

Medical Insurance for Urban Residents

6 (23.0)

2 (7.7)

8 (30.8)

10 (38.5)

  

Medical Insurance for Urban Workers

47 (35.4)

4 (3.0)

58 (43.6)

24 (18.0)

  

Employment Status

    

33.716

 < 0.001

On the job

11 (19.0)

7 (12.0)

23 (39.7)

17 (29.3)

  

Retired

45 (37.8)

5 (4.2)

48 (40.4)

21 (17.6)

  

Unemployed

26 (10.7)

21 (8.6)

79 (32.4)

118 (48.3)

  

Education level

    

27.902

 < 0.001

Primary School or Below

19 (10.9)

17 (9.8)

63 (36.2)

75 (43.1)

  

Junior High School/Technical Secondary School

29 (19.4)

11 (7.3)

48 (32.0)

62 (41.3)

  

Minimum of Senior High School

21 (31.3)

4 (6.0)

25 (37.3)

17 (25.4)

  

Junior College or Above

13 (43.3)

1 (3.3)

14 (46.7)

2 (6.7)

  

Reimbursement Ratio

    

60.656

 < 0.001

≤ 50%

16 (9.8)

20 (12.2)

47 (28.7)

81 (49.3)

  

50% ~ 75%

27 (18.0)

9 (6.0)

53 (35.3)

61 (40.7)

  

> 75%

39 (36.4)

4 (3.7)

50 (46.7)

14 (13.2)

  

Household Monthly Income/Person (Yuan)

    

57.614

 < 0.001

≤ 1000

16 (9.0)

20 (11.3)

49 (27.7)

92 (52.0)

  

1000 ~ 2999

21 (20.0)

4 (3.8)

42 (40.0)

38 (36.2)

  

3000 ~ 4999

19 (27.1)

5 (7.1)

27 (38.7)

19 (27.1)

  

5000 ~ 9999

16 (32.6)

4 (8.2)

24 (49.0)

5 (10.2)

  

> 10,000

10 (50.0)

0 (0.0)

8 (40.0)

2 (10.0)

  

Length of Cancer Diagnosis

    

19.952

 < 0.001

≤ 1 year

68 (22.0)

15 (4.9)

119 (38.5)

107 (34.6)

  

1 ~ 5 years

12 (12.5)

17 (17.5)

25 (25.8)

43 (44.2)

  

5 ~ 10 years

2 (18.2)

0 (0.0)

5 (45.5)

4 (36.3)

  

> 10 years

0 (0.0)

1 (25.0)

1 (25.0)

2 (50.0)

  

Number of Hospitalizations

    

32.168

 < 0.001

≤ 3

32 (27.4)

2 (1.7)

48 (41.0)

35 (29.9)

  

3 ~ 10

32 (19.7)

7 (4.3)

56 (34.6)

67 (41.4)

  

10 ~ 20

14 (23.7)

9 (15.3)

17 (28.8)

19 (32.2)

  

> 20

4 (4.82)

15 (18.07)

29 (34.94)

35 (42.17)

  

Pathological pattern

    

1.182

0.757

Squamous Cell Carcinoma

16 (19.0)

6 (7.1)

34 (40.5)

28 (33.4)

  

Adenocarcinoma

38 (17.9)

15 (7.1)

74 (34.9)

85 (40.1)

  

Adenosquamous Carcinoma

0 (0.0)

1 (20.0)

1 (20.0)

3 (60.0)

  

Other Neuroendocrine Tumors

4 (33.3)

1 (8.3)

2 (16.7)

5 (41.7)

  

Small Cell Cancer

24 (22.9)

10 (9.5)

37 (35.2)

34 (32.4)

  

Other

0 (0.0.)

0 (0.0)

2 (66.7)

1 (33.3)

  

Cancer Stage

    

12.765

0.005

I

4 (30.8)

0 (0.0)

4 (30.8)

5 (38.4)

  

II

8 (25.0)

1 (3.1)

16 (50.0)

7 (21.9)

  

III

24 (20.7)

6 (5.2)

49 (42.2)

37 (31.9)

  

IV

46 (17.6)

26 (10.0)

81 (31.2)

107 (41.2)

  

Distant Metastasis

    

21.277

 < 0.001

Yes

47 (17.0)

32 (11.6)

88 (31.9)

109 (39.5)

  

No

35 (24.1)

1 (0.7)

62 (42.8)

47 (32.4)

  

Chemotherapy

    

0.804

0.849

Yes

74 (19.6)

30 (8.0)

136 (36.1)

137 (36.3)

  

No

8 (18.2)

3 (6.8)

14 (31.8)

19 (43.2)

  

Radiotherapy

    

0.563

0.905

Yes

26 (20.0)

11 (8.5)

43 (33.0)

50 (38.5)

  

No

56 (19.2)

22 (7.6)

107 (36.8)

106 (36.4)

  

Immunotherapy

    

0.900

0.825

Yes

31 (19.7)

13 (8.2)

52 (32.9)

62 (39.2)

  

No

51 (19.4)

20 (7.6)

98 (37.3)

94 (35.7)

  

Targeted Therapy

    

7.164

0.067

Yes

27 (17.9)

16 (10.6)

44 (29.1)

64 (42.4)

  

No

55 (20.4)

17 (6.3)

106 (39.3)

92 (34.0)

  

Operative Treatment

    

0.440

0.932

Yes

14 (20.0)

5 (7.1)

223 (32.9)

28 (40.0)

  

No

68 (19.4)

28 (8.0)

127 (36.1)

128 (36.5)

  

Change Life Style

    

31.572

 < 0.001

Yes

62 (16.2)

32 (8.4)

138 (36.0)

151 (39.4)

  

No

20 (52.6)

1 (2.6)

12 (31.6)

5 (13.2)

  

Change of Medical Plan

    

52.499

 < 0.001

Yes

0 (0.0)

0 (0.0)

3 (8.1)

34 (91.9)

  

No

82 (21.3)

33 (8.6)

147 (38.3)

122 (31.8)

  

Ask Others for Help

    

71.446

 < 0.001

Yes

6 (3.9)

17 (11.0)

40 (26.0)

91 (59.1)

  

No

76 (28.5)

16 (6.0)

110 (41.2)

65 (24.3)

  

Access to Medical Assistance

    

3.683

0.298

Yes

1 (11.1)

0 (0.0)

2 (22.2)

6 (66.7)

  

No

82 (19.7)

33 (8.0)

150 (35.9)

156 (36.4)

  

Commercial Insurance

    

9.125

0.028

Yes

24 (30.4)

4 (5.1)

29 (36.7)

22 (27.8)

  

No

58 (17.0)

29 (8.5)

121 (35.4)

134 (39.1)

 Â